Generic Drug 180-Day Exclusivity Provisions: Hatch Seeks CBO Score

Sen. Orrin Hatch (R-Utah) wants the Congressional Budget Office to help him make the case that 180-day generic drug exclusivity provisions in the Senate and House Medicare bills need revision

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet